Health News Archive

Enter a date to view that day's archives:

Showing 1-20 of 258 stories from the past year.

Halozyme Therapeutics Inc. (Nasdaq: HALO) Thursday announced that the U.S. Food and Drug Administration has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial (S1313).


San Diego is touted as the second-largest hub of sports and active-lifestyle companies in the country, and corporate growth panel attendees on Tuesday heard the stories of three homegrown companies that recently completed capital transactions: prAna, SKLZ and Sanuk.

KUSI-NEWS, Radio Latina and San Diego Family Magazine have stepped forward to support Kids Care Fest, a health fair where more than 1,000 children will receive free health care screenings, including hearing, vision and dental.

Trovagene Inc. (Nasdaq: TROV), a San Diego-based developer of cell-free molecular diagnostics, announced Wednesday that Alberto Bardelli, Ph.D., has joined the company's scientific advisory board.


QPID Health, a developer of clinical intelligence software, Tuesday announced it's opening its first West Coast location in San Diego and moving to new headquarters in Boston.

Beginning this fall and lasting through the Light the Night Walk, the San Diego Marriott La Jolla will be offering a Leukemia & Lymphoma Donation Rate to honor the organization's mission.

OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, has appointed Mai H. Le, M.D. to the position of chief medical officer.


ResMed (NYSE: RMD) announced Monday that its AirView compliance management platform (previously EasyCare Online) is now connected to Fairview Health Services' Epic EHR system, enabling delivery of sleep apnea patient data for use by Fairview's medical staff.


A community-wide symposium on breast health and breast cancer is set for Sept. 30.


Qualcomm Life is rolling out its HealthyCircles connected health platform across many countries over the course of the next year, and expects its presence to not only make life easier for the family caregiver, but to reduce the cost of health care and actually improve the care itself.

San Diego-based Pathway Genomics Corp. has formed a national partnership with the Susan G. Komen breast cancer organization to fund community breast cancer education and outreach programs to five western metropolitan areas, including San Diego.


A friendly challenge focused on ridesharing will run throughout October, but companies must register by Sept. 26.

The San Diego Yacht Club will hold the inaugural Race for Rady to benefit the Rady Children's Hospital.


To combat the lack of access to spinal surgeons and equipment around the world, San Diego-based NuVasive Spine Foundation held a charity golf event Sunday.

The nonprofit Council of Community Clinics announced Monday that three of its member facilities ó Borrego Health, Vista Community Clinic and Clinicas de Salud del Pueblo — have received grants of $250,000 from the federal Health Resources and Services Administration.


About 200 people are expected to begin a three-day walk this Friday along San Diego’s coastline for the National Multiple Sclerosis Society’s 2014 Southern California Challenge Walk.

Ajinomoto Althea Inc., a San Diego-based provider of biopharmaceutical contract development and manufacturing services, has received its European certificate of good manufacturing practice.


The nonprofit Council of Community Clinics announced Monday that three of its member facilities — Borrego Health, Vista Community Clinic and Clinicas de Salud del Pueblo — have received grants of $250,000 from the federal Health Resources and Services Administration.


Isis Pharmaceuticals Inc. (Nasdaq: ISIS) announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS).


Targazyme, Inc. (formerly America Stem Cell Inc.), a clinical-stage biopharmaceutical company, received a Small Business Innovation Research award to fund the development of genetically-modified mesenchymal stem cells treated with Targazyme's lead product, TZ101, for treatment of oral mucositis.

Subscribe Today!